, president-elect of the American Medical Association, said that the group applauded the ruling and would continue to support access to safe and effective" reproductive health care against the ongoing threats of interference in the practice of medicine."
Abortion opponents challenged the FDA's decision in a 2022 lawsuit that sought to withdraw approval of the drug or reinstate dispensing requirements. "The plaintiffs do not prescribe or use mifepristone. And FDA is not requiring them to do or refrain from doing anything," the decision stated."Rather, the plaintiffs want FDA to make mifepristone more difficult for doctors to prescribe and for pregnant women to obtain. Under Article III of the Constitution, a plaintiff's desire to make a drug less available for others does not establish a standing to sue.
Source: Law Daily Report (lawdailyreport.net)
Pregnancy Pregnant Complete Abortion Abortion Complications Abortion Pregnancy Termination Spontaneous Abortion Miscarriage Social Media Patient Safety Reproductive Health Practice Management Revenue Risk Evaluation And Mitigation Strategies REMS - Risk Evaluation And Mitigation Strategies Drug/Treatment Safety Drug Safety Treatment Safety Interference Politics
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: 13WHAM - 🏆 256. / 63 Read more »
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Source: komonews - 🏆 272. / 63 Read more »
Source: FOX10Phoenix - 🏆 83. / 68 Read more »
Source: people - 🏆 712. / 51 Read more »
Source: FoxNews - 🏆 9. / 87 Read more »